Mpm Bioimpact LLC
37 holdingsFiling period: 2026-06-30Current AUM: $1.24Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics, Inc. | 9.73M | $177.2M | $146.3M | 11.84% | +2.08M | 2026-06-30 |
| 2 | AKTS | Aktis Oncology, Inc. | 4.84M | $155.9M | $77.0M | 6.24% | -- | 2026-06-30 |
| 3 | LQDA | Liquidia Corporation | 1.39M | $110.5M | $62.5M | 5.06% | -18,984 | 2026-06-30 |
| 4 | RVMD | Revolution Medicines, Inc. | 492.5K | $92.2M | $94.2M | 7.63% | -14,293 | 2026-06-30 |
| 5 | CORT | Corcept Therapeutics, Inc. | 771.0K | $67.0M | $62.5M | 5.06% | -214,672 | 2026-06-30 |
| 6 | EWTX | Edgewise Therapeutics Inc | 1.62M | $65.9M | $63.0M | 5.10% | -39,916 | 2026-06-30 |
| 7 | TVTX | Travere Therapeutics Inc | 1.12M | $63.8M | $56.6M | 4.58% | -10,634 | 2026-06-30 |
| 8 | DBVT | DBV Technologies S A | 3.67M | $60.1M | $34.8M | 2.82% | -1,547,077 | 2026-06-30 |
| 9 | TRVI | Trevi Therapeutics Inc | 3.07M | $57.3M | $41.7M | 3.37% | -224,853 | 2026-06-30 |
| 10 | ALMS | Alumis Inc | 2.02M | $56.8M | $13.6M | 1.10% | -367,509 | 2026-06-30 |
| 11 | — | Uniqure NV | 1.23M | $56.5M | $56.5M | 4.57% | -143,376 | 2026-06-30 |
| 12 | RARE | Ultragenyx Pharmaceuticals, Inc. | 1.42M | $47.4M | $22.8M | 1.85% | -- | 2026-06-30 |
| 13 | RLAY | Relay Therapeutics Inc. | 2.42M | $45.2M | $44.3M | 3.59% | +56.1K | 2026-06-30 |
| 14 | ABVX | Abivax SA | 336.3K | $44.8M | $29.1M | 2.36% | +229.1K | 2026-06-30 |
| 15 | DYN | Dyne Therapeutics, Inc. | 1.92M | $42.7M | $32.1M | 2.60% | +513.9K | 2026-06-30 |
| 16 | DNTH | Dianthus Therapeutics Inc | 420.0K | $40.9M | $34.6M | 2.80% | -3,980 | 2026-06-30 |
| 17 | BIOA | BIOAGE Labs Inc | 1.67M | $40.9M | $9.8M | 0.79% | -- | 2026-06-30 |
| 18 | — | Urogen Pharma Ltd | 933.4K | $34.3M | $34.3M | 2.78% | -10,388 | 2026-06-30 |
| 19 | MLTX | MoonLake Immunotherapeutics | 1.61M | $31.3M | $18.9M | 1.53% | -204,115 | 2026-06-30 |
| 20 | PVLA | Palvella Therapeutics Inc | 204.0K | $31.2M | $29.8M | 2.41% | -2,377 | 2026-06-30 |
| 21 | TSHA | Taysha Gene Therapies, Inc. | 4.50M | $30.6M | $18.6M | 1.50% | -- | 2026-06-30 |
| 22 | SNDX | Syndax Pharmaceuticals Inc | 1.33M | $29.1M | $18.2M | 1.47% | -7,210 | 2026-06-30 |
| 23 | GLUE | Monte Rosa Therapeutics Inc | 1.16M | $28.1M | $12.5M | 1.01% | -15,847 | 2026-06-30 |
| 24 | — | Zura Bio Ltd. | 4.47M | $26.4M | $26.4M | 2.14% | -- | 2026-06-30 |
| 25 | NTRA | Natera Inc | 92.6K | $25.1M | $38.4M | 3.11% | -436 | 2026-06-30 |
← Scroll →
Page 1 of 2